Journal: Antimicrobial Agents and Chemotherapy
Article Title: Selective Inhibition of Hepatitis C Virus Infection by Hydroxyzine and Benztropine
doi: 10.1128/AAC.02619-14
Figure Lengend Snippet: Selected compounds inhibit early aspects of HCV infection. (A) Huh7 cells were inoculated at a MOI of 10 in the presence of perphenazine (5 μM), hydroxyzine (5 μM), benztropine (7.5 μM), or DMSO as a control. Samples of cells and supernatants were collected to determine infectivity titers as well as intracellular HCV RNA levels by titration and RT-qPCR, respectively, at the indicated time points. (B) Inhibition of HCVtcp infection. Huh-7 cells were inoculated with HCVtcp in the presence of perphenazine (5 μM), hydroxyzine (5 μM), and benztropine (7.5 μM), and samples of the cells were assayed for luciferase activity 48 h postinoculation. Data are shown as averages and standard deviations of the results of two independent experiments performed in triplicate (n = 6). (C) Treatment of Huh-7 cells electroporated with a subgenomic HCV RNA replicon bearing a luciferase gene with perphenazine (5 μM), hydroxyzine (5 μM), benztropine (7.5 μM), or DMSO and 2mAde (10 μM) as negative and positive controls, respectively. Data are shown as averages and standard deviations of the results of two independent experiments performed in duplicate (n = 4). The statistical significance of the differences with the control data set was determined using Student's t test (*, P < 0.05; **, P < 0.01).
Article Snippet: 2mAde (2′-c-methyladenosine) was purchased from BOC Sciences (Shirley, NY).
Techniques: Infection, Titration, Quantitative RT-PCR, Inhibition, Luciferase, Activity Assay